Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 22, 2013

View Archived Issues

Clinical characterization of a novel pleiotropic anti-inflammatory effect of high-dose statin

Medical imaging of a radiolabeled anticancer antibody in patients with breast cancer

TaiGen Biotechnologies describes discovery of pan-genotypic HCV NS3/4A protease inhibitors

Soligenix forms international melioidosis scientific advisory board

MolMed expands phase III TK gene therapy trial to the U.S.

Parent Project Muscular Dystrophy and Sarepta Therapeutics partner for DMD

Stallergenes and DBV Technologies form R&D collaboration for birch pollen allergy

Vertex gives update on cystic fibrosis development programs

Eddingpharm to develop Ablynx product ALX-0141 in China

mGlu2 positive allosteric modulator LY-2607540 chosen for clinical development

MEDI-3379 inhibits tumor growth in trastuzumab-resistant breast cancer models

Evotec and AstraZeneca collaborate on treatments for chronic kidney disease

VGX International initiates phase I study of Inovio's therapeutic vaccine for hepatitis C

Phase I data presented on TRAP-based radiopharmaceutical

Japanese researchers patent new EPO production enhancers

University of Iowa reports novel anticancer agents

Novel TYK2 inhibitors disclosed by Takeda Pharmaceutical

Daiichi Sankyo synthesizes new antinflammatory agents

Team of Japanese researchers designs novel antibodies for multiple myeloma

Seattle Genetics begins phase I study of SGN-LIV1A

FDA approves expanded use of Cubist Pharmaceuticals' Entereg

Rockwell Medical reports results of short-term safety study of iron replacement drug

Regeneron reports data from phase III study of Eylea for macular edema following BRVO

FDA submission for Arzerra in previously untreated CLL

Genalyte receives SBIR grant from NCI to develop cancer biomarker panel

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...